Circular RNAs Interaction with MiRNAs: Emerging Roles in Breast Cancer

Liu Gong1, XiaoYun Zhou1, Jiping Sun1

  • 1Department of Medical Oncology, Hangzhou Xiasha Hospital, Hangzhou, Zhejiang Province, China.

Insights

Circular RNAs (circRNAs) are novel RNA molecules implicated in cancer. This review explores their function, particularly as microRNA sponges, in breast cancer development and progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Breast cancer remains a leading cause of cancer mortality globally, necessitating novel therapeutic and diagnostic strategies.
  • Next-generation sequencing has revealed a new class of RNA molecules, circular RNAs (circRNAs), offering insights into cancer pathogenesis.
  • Circular RNAs are stable, covalently closed RNA molecules derived from precursor mRNA back-splicing, primarily functioning as microRNA sponges.

Purpose of the Study:

  • To review the biogenesis, characteristics, and functional mechanisms of circRNAs.
  • To discuss the deregulation of circRNAs in various cancers.
  • To focus on the role of circRNAs as microRNA sponges in breast cancer progression, including development, metastasis, angiogenesis, drug resistance, apoptosis, and immune response.

Main Methods:

  • Literature review of studies on circRNA biogenesis, function, and roles in cancer.
  • Analysis of evidence linking circRNA aberrant expression to cancer hallmarks.
  • Focused review on circRNAs' function as miRNA sponges in breast cancer.

Main Results:

  • Circular RNAs exhibit unique biogenesis and stable structures, primarily acting as miRNA sponges.
  • Aberrant expression of circRNAs is associated with multiple hallmarks of cancer.
  • circRNAs play significant roles in breast cancer development, metastasis, angiogenesis, drug resistance, apoptosis, and immune evasion.

Conclusions:

  • Circular RNAs represent a promising area for understanding breast cancer etiology and developing biomarkers.
  • Their function as miRNA sponges is a key mechanism underlying their involvement in breast cancer.
  • Further research into circRNAs could lead to novel diagnostic and therapeutic interventions for breast cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.5K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.1K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K